Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Income: 2022-2025

Historic Net Income for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Net Income fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
  • Per Gossamer Bio's latest filing, its Net Income stood at -$48.2 million for Q3 2025, which was down 31.61% from -$36.6 million recorded in Q2 2025.
  • Gossamer Bio's Net Income's 5-year high stood at -$30.8 million during Q3 2024, with a 5-year trough of -$59.0 million in Q3 2022.
  • Moreover, its 3-year median value for Net Income was -$41.9 million (2024), whereas its average is -$42.1 million.
  • Its Net Income has fluctuated over the past 5 years, first soared by 32.23% in 2023, then crashed by 56.55% in 2025.
  • Gossamer Bio's Net Income (Quarterly) stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then soared by 31.40% to -$33.0 million in 2024, then crashed by 56.55% to -$48.2 million in 2025.
  • Its Net Income was -$48.2 million in Q3 2025, compared to -$36.6 million in Q2 2025 and -$39.3 million in Q1 2025.